Central Nervous System Cancer
📧 Sign up to get email alerts when something new happens for Central Nervous System Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Study of Stored Tumor Samples in Young Patients With Brain Tumors
Clinical trial update indicates that the study of stored tumor samples from young patients with brain tumors conducted at St. Jude has been …
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas [Phase 2]
Phase II trial of perifosine for recurrent/progressive malignant gliomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 [NA]
A terminated clinical trial evaluating an iodine-131–labeled monoclonal antibody (8H9) for central nervous system cancers and neuroblastoma …
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of D-Methadone in Patients With Chronic Pain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-Methadone in patients with chronic pain and various cancers has completed enrollment with results po…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma [Phase 2]
Phase II trial of sunitinib in patients with recurrent or inoperable meningioma has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors [Phase 2]
Phase 2 trial evaluating the combination of tamoxifen, carboplatin, and topotecan in patients with brain or spinal CNS tumors; the study sta…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors [Phase 1]
This early-phase trial assesses the safety and feasibility of combining irinotecan and thalidomide in patients with recurrent central nervou…